146 related articles for article (PubMed ID: 30963309)
21. Novel insights into genetics and clinics of the HNF1A-MODY.
Valkovicova T; Skopkova M; Stanik J; Gasperikova D
Endocr Regul; 2019 Apr; 53(2):110-134. PubMed ID: 31517624
[TBL] [Abstract][Full Text] [Related]
22. Co-inheritance of HNF1a and GCK mutations in a family with maturity-onset diabetes of the young (MODY): implications for genetic testing.
López-Garrido MP; Herranz-Antolín S; Alija-Merillas MJ; Giralt P; Escribano J
Clin Endocrinol (Oxf); 2013 Sep; 79(3):342-7. PubMed ID: 23009393
[TBL] [Abstract][Full Text] [Related]
23. Decreased GLUT2 and glucose uptake contribute to insulin secretion defects in MODY3/HNF1A hiPSC-derived mutant β cells.
Low BSJ; Lim CS; Ding SSL; Tan YS; Ng NHJ; Krishnan VG; Ang SF; Neo CWY; Verma CS; Hoon S; Lim SC; Tai ES; Teo AKK
Nat Commun; 2021 May; 12(1):3133. PubMed ID: 34035238
[TBL] [Abstract][Full Text] [Related]
24. A multigenerational study on phenotypic consequences of the most common causal variant of HNF1A-MODY.
Kettunen JLT; Rantala E; Dwivedi OP; Isomaa B; Sarelin L; Kokko P; Hakaste L; Miettinen PJ; Groop LC; Tuomi T
Diabetologia; 2022 Apr; 65(4):632-643. PubMed ID: 34951657
[TBL] [Abstract][Full Text] [Related]
25. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young.
Ellard S; Colclough K
Hum Mutat; 2006 Sep; 27(9):854-69. PubMed ID: 16917892
[TBL] [Abstract][Full Text] [Related]
26. INS-1 cells undergoing caspase-dependent apoptosis enhance the regenerative capacity of neighboring cells.
Bonner C; Bacon S; Concannon CG; Rizvi SR; Baquié M; Farrelly AM; Kilbride SM; Dussmann H; Ward MW; Boulanger CM; Wollheim CB; Graf R; Byrne MM; Prehn JH
Diabetes; 2010 Nov; 59(11):2799-808. PubMed ID: 20682686
[TBL] [Abstract][Full Text] [Related]
27. Expression of mutant mRNA and protein in pancreatic cells derived from MODY3- iPS cells.
Yabe SG; Nishida J; Fukuda S; Takeda F; Nasiro K; Yasuda K; Iwasaki N; Okochi H
PLoS One; 2019; 14(5):e0217110. PubMed ID: 31145732
[TBL] [Abstract][Full Text] [Related]
28. Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes.
Mughal SA; Park R; Nowak N; Gloyn AL; Karpe F; Matile H; Malecki MT; McCarthy MI; Stoffel M; Owen KR
Diabet Med; 2013 Feb; 30(2):246-50. PubMed ID: 23157689
[TBL] [Abstract][Full Text] [Related]
29. Clinical application of ACMG-AMP guidelines in HNF1A and GCK variants in a cohort of MODY families.
Santana LS; Caetano LA; Costa-Riquetto AD; Quedas EPS; Nery M; Collett-Solberg P; Boguszewski MCS; Vendramini MF; Crisostomo LG; Floh FO; Zarabia ZI; Kohara SK; Guastapaglia L; Passone CGB; Sewaybricker LE; Jorge AAL; Teles MG
Clin Genet; 2017 Oct; 92(4):388-396. PubMed ID: 28170077
[TBL] [Abstract][Full Text] [Related]
30. Bone morphogenetic protein 3 controls insulin gene expression and is down-regulated in INS-1 cells inducibly expressing a hepatocyte nuclear factor 1A-maturity-onset diabetes of the young mutation.
Bonner C; Farrelly AM; Concannon CG; Dussmann H; Baquié M; Virard I; Wobser H; Kögel D; Wollheim CB; Rupnik M; Byrne MM; König HG; Prehn JH
J Biol Chem; 2011 Jul; 286(29):25719-28. PubMed ID: 21628466
[TBL] [Abstract][Full Text] [Related]
31. Human iPSCs-Derived Endothelial Cells with Mutation in
Kachamakova-Trojanowska N; Stepniewski J; Dulak J
Cells; 2019 Nov; 8(11):. PubMed ID: 31739614
[TBL] [Abstract][Full Text] [Related]
32. Three unreported glucokinase (GCK) missense mutations detected in the screening of thirty-two Brazilian kindreds for GCK and HNF1A-MODY.
Weinert LS; Silveiro SP; Giuffrida FM; Cunha VT; Bulcão C; Calliari LE; Della Manna T; Kunii IS; Dotto RP; Dias-da-Silva MR; Reis AF
Diabetes Res Clin Pract; 2014 Nov; 106(2):e44-8. PubMed ID: 25174781
[TBL] [Abstract][Full Text] [Related]
33. An alternative approach using hs-CRP levels and age of onset in diagnostics of HNF1A-MODY.
Kickova T; Skopkova M; Dobiasova Z; Lackova G; Belicova Z; Schenkova K; Stanik J; Gasperikova D
Diabet Med; 2024 May; 41(5):e15265. PubMed ID: 38093550
[TBL] [Abstract][Full Text] [Related]
34. Mexican Carriers of the
Martagón AJ; Bello-Chavolla OY; Arellano-Campos O; Almeda-Valdés P; Walford GA; Cruz-Bautista I; Gómez-Velasco DV; Mehta R; Muñoz-Hernández L; Sevilla-González M; Viveros-Ruiz TL; Ordoñez-Sánchez ML; Rodríguez-Guillen R; Florez JC; Tusié-Luna MT; Aguilar-Salinas CA;
Diabetes Care; 2018 Aug; 41(8):1726-1731. PubMed ID: 29844095
[TBL] [Abstract][Full Text] [Related]
35. Divergent phenotypes in siblings with identical novel mutations in the HNF-1α gene leading to maturity onset diabetes of the young type 3.
Knebel B; Mack S; Haas J; Herman-Friede MK; Lange S; Schubert O; Kotzka J; Muller-Wieland D
BMC Med Genet; 2016 May; 17(1):36. PubMed ID: 27142837
[TBL] [Abstract][Full Text] [Related]
36. Reduced calcium levels and accumulation of abnormal insulin granules in stem cell models of HNF1A deficiency.
González BJ; Zhao H; Niu J; Williams DJ; Lee J; Goulbourne CN; Xing Y; Wang Y; Oberholzer J; Blumenkrantz MH; Chen X; LeDuc CA; Chung WK; Colecraft HM; Gromada J; Shen Y; Goland RS; Leibel RL; Egli D
Commun Biol; 2022 Aug; 5(1):779. PubMed ID: 35918471
[TBL] [Abstract][Full Text] [Related]
37. Characterization of beta cell and incretin function in patients with MODY1 (HNF4A MODY) and MODY3 (HNF1A MODY) in a Swedish patient collection.
Ekholm E; Shaat N; Holst JJ
Acta Diabetol; 2012 Oct; 49(5):349-54. PubMed ID: 21761282
[TBL] [Abstract][Full Text] [Related]
38. Genetic and clinical characteristics of patients with HNF1A gene variations from the German-Austrian DPV database.
Awa WL; Thon A; Raile K; Grulich-Henn J; Meissner T; Schober E; Holl RW;
Eur J Endocrinol; 2011 Apr; 164(4):513-20. PubMed ID: 21224407
[TBL] [Abstract][Full Text] [Related]
39. Lower Circulating miR-122 Level in Patients with HNF1A Variant-Induced Diabetes Compared with Type 2 Diabetes.
Huang X; Gong S; Ma Y; Cai X; Zhou L; Luo Y; Li M; Liu W; Zhang S; Zhang X; Ren Q; Zhu Y; Zhou X; Zhang R; Chen L; Gao X; Zhang F; Wang Y; Han X; Ji L
J Diabetes Res; 2018; 2018():7842064. PubMed ID: 30155490
[TBL] [Abstract][Full Text] [Related]
40. HNF1A mutation presenting with fetal macrosomia and hypoglycemia in childhood prior to onset of overt diabetes.
Dusátková P; Průhová S; Sumník Z; Kolousková S; Obermannová B; Cinek O; Lebl J
J Pediatr Endocrinol Metab; 2011; 24(5-6):377-9. PubMed ID: 21823540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
